Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies

Einsele H, Briones J, Ciceri F, Garcia-Cadenas I, Falkenburg F, Bolanos N, Heemskerk HMM, Houot R, Hudecek M, Locatelli F, Morgan K, Morris CE, O'Dwyer M, Gil JS, Van Den Brink M, Van De Loosdrecht AA (2020)

Publication Type: Journal article

Publication year: 2020

Journal

HemaSphere Lippincott, Williams & Wilkins

Book Volume: 4

Article Number: e423

Journal Issue: 4

DOI: 10.1097/HS9.0000000000000423

Involved external institutions

Hospital de la Santa Creu i Sant Pau

Spain (ES) Università Vita-Salute San Raffaele (UniSR)

Italy (IT) Leiden University Medical Center

Netherlands (NL) Università degli studi "La Sapienza"

Italy (IT) Myeloma UK

United Kingdom (GB) Royal Free Hospital

United Kingdom (GB) University Hospital Galway

Ireland (IE) Memorial Sloan Kettering Cancer Center

United States (USA) (US) Vrije Universiteit Amsterdam (VU) / University Amsterdam

Netherlands (NL) Universitätsklinikum Würzburg

Germany (DE) Lymphoma Coalition Europe

France (FR) Université de Rennes 1 / University of Rennes 1

France (FR)

How to cite

APA:

Einsele, H., Briones, J., Ciceri, F., Garcia-Cadenas, I., Falkenburg, F., Bolanos, N.,... Van De Loosdrecht, A.A. (2020). Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies. HemaSphere, 4(4). https://doi.org/10.1097/HS9.0000000000000423

MLA:

Einsele, Hermann, et al. "Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies." HemaSphere 4.4 (2020).

BibTeX: Download